{"id":"C1954L00093","name":"National Health (Pharmaceutical Benefits) Regulations (Amendment)","slug":"national-health-pharmaceutical-benefits-regulations-amendment","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":"93 of 1954","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":23538,"registerId":"commonwealth-C1954L00093-current","compilationNumber":null,"startDate":"2026-04-01","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health (Pharmaceutical Benefits) Regulations (Amendment)","content":"STATUTORY RULES.\n\n1954\\. No. 93\n\n![](image.001.png)REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953.\\*\n\nI, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.\n\nDated this eighteenth\n\nday of August , 1954.\n\nW. J. Slim\n\nGovernor-General.\n\nBy His Excellency’s Command,\n\n![Signature of Earle Page](image.002.png)\n\nMinister of State for Health.\n\n![](image.003.png)Amendments of the National Health (Pharmaceutical Benefits) Regulations.†\n\nInterpretation.\n\n1. Regulation 2 of the National Health (Pharmaceutical Benefits) Regulations is amended—\n\n(a) by inserting in sub-regulation (1.), after the definition of\n\n“authorized prescription form”, the following definition:—\n\n![](image.004.png)“‘brand’ means a brand of a pharmaceutical benefit in respect of which the Minister has determined a rate of payment;”;\n\n\\* Notified in the Commonwealth Gazette on , 1954\n\n† Statutory Rules 1954, No. 54, as amended by Statutory Rules 1954, Nos. 77\n\n3037.—Price 1s. 6d. 10/3.8.1954.\n\n \n\n(b) by omitting from paragraph (a) of sub-regulation (2.) the word “and” (last occurring); and\n\n(c) by omitting paragraph (b) of sub-regulation (2.).\n\nGeneral pharmaceutical benefits.\n\n2. Regulation 8 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting sub-regulation (4.) and inserting in its stead the following sub-regulation:—\n\n“(4.) Water for Injection as prescribed in the First Schedule is not a general pharmaceutical benefit unless it is prescribed for supply in conjunction with and for administration with—\n\n(a) a drug or medicinal preparation that is prescribed as a general pharmaceutical benefit in the form of a hypodermic tablet; or\n\n(b) one of the following drugs or medicinal preparations as prescribed as general pharmaceutical benefits:—\n\nAureomycin.\n\nDihydrostreptomycin.\n\nHyalase.\n\nInjection of Neoarsphenamine.\n\nPenethamate Hydriodide.\n\nInjection of Penicillin.\n\nInjection of Phenobarbitone Sodium.\n\nInjection of Procaine Penicillin (Crystalline).\n\nRondase.\n\nStreptomycin.\n\nTerramycin.\n\nTetracycline.\n\nWydase.”.\n\nExceptions to pensioner benefits in British Pharmacopoeia.\n\n3. Regulation 9 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting paragraph (b) of sub-regulation (1.).\n\nWriting of prescriptions.\n\n4. Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from paragraph (e) of sub-regulation (1.) the words “by the trade name of a manufacturer an abbreviation of whose name appears in the column headed ‘Brand’ in that Schedule” and inserting in their stead the words “by a brand of that benefit”.\n\nFirst, Second and Third Schedules.\n\n5. The First, Second and Third Schedules to National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—\n\n![](image.005.png)FIRST SCHEDULE. Reg. 8.\n\n![](image.006.png)Drugs and Medicinal Preparations that may be Prescribed for Supply, Supplied and Received as General Pharmaceutical Benefits.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

1

Acetarsol Soluble, Injection of ..........

..........................

2 cc. amp....................

10

1

..........................

3 cc. amp....................

10

1

2

Adrenalin Hydrochloride, Solution of

1 in 1,000 ...................

0.5 cc. amp...................

6

1

1 in 1,000 ...................

1 cc. amp....................

6

1

1 in 1,000 ...................

10 cc. vial ...................

1

1

1 in 1,000 ...................

1 fl. oz. bottle .................

1

..

1 in 1,000 ...................

1 fl. oz. vial ..................

1

..

1 in 100 .....................

6 cc. vial ....................

1

..

1 in 100 .....................

10 cc. vial ...................

1

3

Adrenalin in Oil, Injection of ...........

2 mg. per cc...................

1 cc. amp....................

6

1

4

Adrenalin Tartrate, Solution of ..........

1 in 1,000 ...................

1 cc. amp....................

6

1

1 in 1,000 ...................

10 cc. amp....................

1

1

1 in 1,000 ...................

25 cc. bottle ..................

1

..

1 in 1,000 ...................

30 cc. vial ...................

1

..

1 in 1,000 ...................

1 fl. oz. bottle .................

1

..

1 in 100 .....................

7 cc. vial ....................

1

..

5

Aloxidone ........................

0.3 G.......................

capsule .....................

100

1

6

Amidone .........................

5 mg. per cc...................

2 cc. amp....................

6

..

5 mg. per cc...................

10 cc. vial ...................

1

..

10 mg. per cc..................

1 cc. amp....................

6

..

10 mg. per cc..................

10 cc. vial ...................

1

..

10 mg. per cc..................

20 cc. vial ...................

1

..

2.5 mg. .....................

tablet ......................

25

..

5 mg. ......................

tablet ......................

25

..

7.5 mg. .....................

tablet ......................

25

..

10 mg.......................

tablet ......................

25

..

\n```\n\n![](image.008.png)![](image.007.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ---------------------------------------- | -------------------------------- | ---------------------------------- | ------------------------------------ | ------------------ |\n| 7 | Amyl Nitrite ....................... | 2 min....................... | capsule ...................... | 12 | 1 |\n| | | 3 min....................... | capsule ...................... | 12 | 1 |\n| | | 4 min....................... | capsule ...................... | 12 | 1 |\n| | | 5 min. ..................... | capsule ...................... | 12 | 1 |\n| 8 | Anahaemin ....................... | .......................... | 2 cc. amp..................... | 12 | 1 |\n| 9 | Anahepol ......................... | .......................... | 2 cc. amp..................... | 12 | 1 |\n| 10 | Antazoline, Injection of ............... | 0.1 G. per 2 cc................. | 2 cc. amp..................... | 10 | .. |\n| 11 | Atropine Sulphate ................... | 1/150 gr. per cc................ | 1 cc. amp..................... | 6 | 1 |\n| | | 1/100 gr. per cc ............... | 1 cc. amp. .................... | 6 | 1 |\n| | | 1/100 gr. per cc ............... | 10 cc. vial .................... | 1 | .. |\n| | | 1/50 gr. Per cc ................ | 1 cc. amp. .................... | 6 | 1 |\n| | | 1/100 gr. .................... | hypo. tab. | 20 | 1 |\n| | | 1/150 gr..................... | hypo. tab. .................... | 20 | 1 |\n| | | 1/100 gr. .................... | hypo. tab. .................... | 20 | 1 |\n| 12 | Aurothioglucose, Oily Injection of | 0.01 G. ..................... | amp......................... | 1 | 3 |\n| | | 0.025 G. .................... | amp......................... | 1 | 3 |\n| | | 0.05 G...................... | amp......................... | 6 | .. |\n| | | 0.1 G....................... | amp......................... | 6 | .. |\n| | | 0.01 G. per cc................. | 10 cc. vial .................... | 1 | .. |\n| | | 0.1 G. per cc.................. | 10 cc. vial .................... | 1 | .. |\n| 13 | Benzhexol Hydrochloride .............. | 2 mg....................... | tablet ....................... | 100 | 1 |\n| | | 5 mg....................... | tablet ....................... | 100 | 1 |\n| 14 | Bismuth, Aqueous Injection of | .......................... | 5 cc. amp..................... | 2 | .. |\n| | | .......................... | 10 cc. amp.................... | 1 | .. |\n| | | .......................... | 25 cc. bottle .................. | 1 | .. |\n| | | .......................... | 1 fl. oz. bottle ................. | 1 | .. |\n\n![](image.010.png)![](image.009.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

15

Bismuth Oxychloride, Aqueous Injection of

..........................

1 cc. amp.....................

12

..

..........................

2 cc. amp.....................

12

..

..........................

3 cc. amp.....................

12

..

..........................

25 cc. bottle ..................

1

..

..........................

30 cc. bottle ..................

1

..

16

Bismuth Oxychloride, Oily Injection of

..........................

2 cc. amp.....................

12

..

..........................

3 cc. amp.....................

12

..

17

Bismuth Salicylate, Oily Injection of

..........................

1 cc. amp.....................

12

..

..........................

10 cc. amp....................

6

..

..........................

25 cc. bottle..................

1

..

..........................

50 cc. bottle..................

1

..

..........................

60 cc. bottle..................

1

..

..........................

2 fl. oz. bottle.................

1

..

18

Calcium Aurothiomalate, Injection of

10 mg.......................

amp........................

1

3

25 mg.......................

amp........................

1

3

50 mg.......................

amp........................

6

..

100 mg......................

amp........................

6

..

19

Calf Lymph..................

..........................

capillary tube .................

1

..

20

Camoquin Hydrochloride.........

0.2 G.......................

tablet ......................

25

..

21

Campolon...................

..........................

2 cc. amp.....................

6

1

..........................

5 cc. amp.....................

6

1

..........................

10 cc. vial ...................

1

1

22

Campolon Forte...............

..........................

1 cc. amp.....................

6

1

..........................

5 cc. vial ....................

1

1

..........................

10 cc. vial ...................

1

1

\n```\n\n![](image.012.png)![](image.011.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ----------------------------------------- | -------------------------------- | --------------------------------- | ------------------------------------ | ------------------ |\n| 23 | Carbachol......................... | 0.25 mg. per cc................. | 1 cc. amp..................... | 6 | .. |\n| | | 2 mg........................ | tablet....................... | 25 | 3 |\n| 24 | Carbarsone........................ | 0.25 G...................... | capsule..................... | 20 | 1 |\n| | | 0.25 G...................... | tablet....................... | 20 | 1 |\n| 25 | Casydrol.......................... | 2½%....................... | 500 cc. bottle................. | 1 | .. |\n| | | 5%........................ | 500 cc. bottle................. | 1 | .. |\n| 26 | Chiniofon......................... | 0.25 G...................... | pill........................ | 25 | 1 |\n| | | 0.25 G...................... | tablet....................... | 25 | 1 |\n| | | 0.5 G....................... | tablet....................... | 25 | 1 |\n| 27 | Chloroquine....................... | 0.2 G....................... | tablet....................... | 100 | 1 |\n| | | 250 mg...................... | tablet....................... | 100 | 1 |\n| 28 | Cholera Vaccine..................... | 4,000 M. per cc................ | 1 cc. amp..................... | 3 | .. |\n| | | 4,000 M. per cc................ | 10 cc. vial.................... | 1 | .. |\n| | | 8,000 M. per cc................ | 1 cc. amp..................... | 2 | .. |\n| | | 8,000 M. per cc................ | 10 cc vial.................... | 1 | .. |\n| 29 | Dapsone.......................... | 50 mg....................... | tablet ...................... | 100 | .. |\n| | | 100 mg...................... | tablet ...................... | 100 | .. |\n| 30 | Darrow’s Solution................... | .......................... | 1 litre bottle .................. | 2 | 1 |\n| 31 | Dextrose, Aqueous Injection of........... | 5%........................ | 1 litre bottle .................. | 6 | 1 |\n| | | 10%....................... | 1 litre bottle .................. | 2 | 1 |\n| | | 20%....................... | 1 litre bottle .................. | 2 | 1 |\n| | | 25%....................... | 1 litre bottle .................. | 2 | 1 |\n| | | 50%....................... | 25 cc. amp.................... | 6 | 1 |\n| | | 60%....................... | 50 cc. amp.................... | 6 | 1 |\n\n![](image.014.png)![](image.013.png) \nFirst Schedule—continued.\n\n| ItemNumber. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantityor Number of Units. | Number of Repeats. |\n| ----------- | ----------------------------------------- | ------------------------------- | --------------------------------- | ----------------------------------- | ------------------ |\n| 32 | Dextrose in ⅕ Normal Saline for Injection | 4%........................ | 1 litre bottle................... | 6 | 1 |\n| 33 | Dextrose in Ringer’s Solution for | 5%........................ | 1 litre bottle................... | 6 | 1 |\n| | Injection | 10%....................... | 1 litre bottle................... | 3 | 1 |\n| 34 | Diasone.......................... | 0.33 G...................... | tablet....................... | 200 | 1 |\n| 35 | Dicoumarol........................ | 100 mg...................... | amp........................ | 3 | |\n| | | 50 mg....................... | capsule...................... | 50 | 1 |\n| | | 100 mg...................... | capsule...................... | 50 | 1 |\n| | | 50 mg....................... | tablet....................... | 50 | 1 |\n| 36 | Diethazine Hydrochloride.............. | 0.05 G...................... | tablet....................... | 100 | 1 |\n| | | 0.25 G...................... | tablet....................... | 100 | 1 |\n| 37 | Diethylcarbamazine.................. | 50 mg....................... | tablet....................... | 20 | 1 |\n| 38 | Digifortis......................... | ½ gr....................... | tablet....................... | 50 | 1 |\n| | | 1 gr........................ | tablet....................... | 50 | 1 |\n| 39 | Digitalis.......................... | ½ gr....................... | tablet....................... | 100 | 1 |\n| | | 1 gr........................ | tablet....................... | 100 | 1 |\n| 40 | Digitoxin | 1/100 gr..................... | hypo. tab..................... | 20 | 1 |\n| | | 0.1 mg...................... | tablet....................... | 100 | 1 |\n| | | 0.2 mg...................... | tablet....................... | 100 | 1 |\n| | | 0.25 mg..................... | tablet....................... | 100 | 1 |\n| 41 | Digoxin.......................... | 0.5 mg. per cc................. | 1 cc. amp..................... | 12 | 1 |\n| | | 0.5 mg. per cc................. | 30 cc. bottle................... | 1 | 1 |\n| | | 0.25 mg..................... | tablet....................... | 100 | 1 |\n\n![](image.016.png)![](image.015.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity
or Number of Units.

Number of Repeats.

42

Dihydroergotamine, Injection of ..........

1 mg. per cc...................

1 cc. amp....................

6

..

43

Dihydromorphinone..................

..........................

1.1 cc. amp...................

4

..

1/32 gr...................

hypo. tab.....................

20

..

1/20 gr......................

hypo. tab.....................

20

..

1/26 gr......................

tablet.......................

20

..

44

Diiodohydroxyquinoline................

0.21 G......................

tablet.......................

100

1

0.3 G.......................

tablet.......................

100

1

45

Dimercaprol, Injection of...............

..........................

2 cc. amp....................

12

46

Diphenhydramine Hydrochloride, Injection of

10 mg. per cc. ................

10 cc. vial...................

1

1

47

Diphtheria and Tetanus Toxoids Combined

..........................

1 cc. amp....................

3

..

..........................

5 cc. amp....................

1

..

48

Diphtheria Antitoxin..................

1,000 U.....................

amp........................

2

1

2,000 U.....................

amp........................

2

1

4,000 U.....................

amp........................

2

1

6,000 U.....................

amp........................

2

1

8,000 U.....................

amp........................

2

1

10,000 U.....................

amp........................

2

1

20,000 U.....................

amp........................

2

1

49

Diphtheria Pertussis Antigen.............

..........................

1 cc. amp....................

3

..

..........................

5 cc. amp....................

1

..

..........................

5 cc. vial....................

1

..

..........................

7.5 cc. vial...................

1

..

..........................

10 cc. vial ...................

1

..

\n```\n\n![](image.018.png)![](image.017.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

50

Diphtheria, Pertussis and Tetanus Antigen

..........................

1 cc. amp.....................

3

..

..........................

5 cc. amp.....................

1

..

..........................

7.5 cc. vial...................

1

..

..........................

10 cc. vial...................

1

..

51

Diphtheria Prophylactic (Formalinized Toxoid)

..........................

set containing 3 amps. each 1 cc. Toxoid undiluted and 1 amp. of 1 cc. Toxoid diluted

1

1

..........................

set containing 9 amps. each 1 cc. Toxoid undiluted and 3 amps. of 1 cc. Toxoid diluted

1

..

52

Diphtheria Prophylactic (Purified Toxoid Aluminium Phosphate)

..........................

1 cc. amp.....................

2

1

..........................

5 cc. vial....................

1

..

..........................

10 cc. vial...................

1

..

..........................

set containing 2 amps. each 1 cc. Toxoid for use in adults and 1 amp. of 1 cc. Toxoid diluted for skin test

1

..

53

Diphtheria Toxoid Purified (Diluted for skin test only)

..........................

1 cc. amp.....................

1

..

54

Emetine Hydrochloride................

20 mg. per cc..................

1 cc. amp.....................

12

..

30 mg. per cc..................

1 cc. amp.....................

12

..

65 mg. per cc..................

1 cc. amp.....................

6

..

½ gr.......................

tablet.......................

12

..

55

Emetine Bismuth Iodide...............

1 gr.......................

tablet.......................

25

1

2 gr.......................

tablet.......................

25

1

56

Entero-vioform.....................

0.25 G......................

tablet.......................

100

1

\n```\n\n![](image.020.png)![](image.019.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | MaximumQuantity or Number of Units. | Number of Repeats. |\n| ------------ | ---------------------------------------- | -------------------------------- | -------------------------------- | ----------------------------------- | ------------------ |\n| 57 | Ephedrine Hydrochloride............... | ½ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |\n| | | ¾ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |\n| | | ½ gr........................ | hypo. tab..................... | 20 | 1 |\n| | | ¼ gr........................ | tablet ...................... | 100 | 1 |\n| | | ½ gr........................ | tablet ...................... | 100 | 1 |\n| | | 1 gr........................ | tablet ...................... | 100 | 1 |\n| 58 | Ephedrine Sulphate................... | ½ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |\n| | | 5%........................ | 1 cc. amp..................... | 6 | 1 |\n| | | 3/8 gr....................... | capsule..................... | 40 | 1 |\n| | | ¾ gr........................ | capsule..................... | 40 | 1 |\n| | | ½ gr........................ | hypo. tab..................... | 20 | 1 |\n| | | ¼ gr........................ | tablet....................... | 100 | 1 |\n| | | ½ gr........................ | tablet....................... | 100 | 1 |\n| 59 | Ergometrine Maleate.................. | 0.2 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |\n| | | 0.5 mg. per cc.................. | 1 cc. I.M. amp................. | 6 | .. |\n| | | 0.125 mg. per cc................ | 1 cc. I.V. amp.................. | 6 | .. |\n| | | 0.2 mg....................... | tablet ...................... | 25 | .. |\n| | | 0.5 mg....................... | tablet....................... | 25 | .. |\n| 60 | Ergot (Prepared)..................... | ........................... | 1 cc. amp..................... | 6 | .. |\n| | | 2½ gr....................... | capsule..................... | 25 | 1 |\n| | | 2½ gr....................... | tablet....................... | 25 | 1 |\n| | | 4 gr........................ | tablet....................... | 25 | 1 |\n| 61 | Ergotamine Tartrate.................. | ........................... | 0.5 cc. amp................... | 6 | .. |\n| | | ........................... | 1 cc. amp..................... | 6 | .. |\n| | | 1 mg........................ | tablet....................... | 15 | 1 |\n| 62 | ergotoxine Ethanesulphonate............. | 0.5 mg....................... | tablet....................... | 25 | .. |\n| 63 | Ethopropazine Hydrochloride............ | 50 mg....................... | tablet....................... | 100 | 1 |\n\n![](image.022.png)![](image.021.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantityor Number of Units. | Number of Repeats. |\n| ------------ | ------------------------------------------ | ------------------------------ | --------------------------------- | ----------------------------------- | ------------------ |\n| 64 | Ethyl Biscoumacetate.................. | 300 mg...................... | tablet....................... | 100 | .. |\n| 65 | Ethylidene Dicoumarin................. | 100 mg...................... | tablet....................... | 50 | 1 |\n| 66 | Examen........................... | ........................... | 1 cc. amp..................... | 12 | 1 |\n| | | ........................... | 5 cc. amp..................... | 1 | 1 |\n| 67 | Exatrope.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |\n| | | ........................... | 12 cc. amp.................... | 1 | 1 |\n| 68 | Gas Gangrene Antitoxin (Oedematiens) | 10,000 U..................... | amp........................ | 3 | 1 |\n| 69 | Gas Gangrene Antitoxin (Perfringens) | 4,000 U...................... | amp........................ | 3 | 1 |\n| | | 10,000 U..................... | amp........................ | 10 | 1 |\n| 70 | Gas Gangrene Antitoxin (Polyvalent) | 3,000 U. perfringens | | | |\n| | | 1,500 U. septique | 1 amp....................... | 2 | 1 |\n| | | 1,000 U. oedematiens | | | |\n| | | 7,500 U. perfringens | | | |\n| | | 3,750 U. septique | 1 amp....................... | 2 | 1 |\n| | | 2,500 U. oedematiens | | | |\n| 71 | Gas Gangrene Antitoxin (Septique)......... | 5,000 U...................... | amp........................ | 2 | 1 |\n| 72 | Glyceryl Trinitrate.................... | 1/100 gr...................... | hypo. tab..................... | 50 | 1 |\n| | | 1/200 gr...................... | tablet ...................... | 50 | 1 |\n| | | 1/150 gr...................... | tablet ...................... | 50 | 1 |\n| | | 1/130 gr...................... | tablet ...................... | 50 | 1 |\n| | | 1/100 gr...................... | tablet ...................... | 50 | 1 |\n| | | 1/65 gr....................... | tablet ...................... | 50 | 1 |\n| | | 1/50 gr....................... | tablet ...................... | 50 | 1 |\n| 73 | Hartmann’s Solution.................. | ........................... | 1 litre bottle .................. | 2 | 1 |\n\n![](image.026.png)![](image.025.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ----------------------------------------- | --------------------------------- | -------------------------------- | ------------------------------------ | ------------------ |\n| 74 | Hartmann’s Solution with Dextrose | 50%....................... | 1 litre bottle.................. | 2 | 1 |\n| | | 10%....................... | 1 litre bottle.................. | 2 | 1 |\n| 75 | Heparin, Injection of.................. | 1,000 U. per cc................. | 5 cc. vial.................... | 5 | .. |\n| | | 1,000 U. per cc................. | 10 cc. vial.................... | 1 | .. |\n| | | 5,000 U. per cc................. | 5 cc. vial.................... | 1 | .. |\n| | | 25,000 U. per cc................ | 5 cc. vial.................... | 1 | .. |\n| 76 | Heparin Retard, Injection of............. | 20,000 U. per 2 mil.............. | 2 mil. amp.................... | 6 | .. |\n| 77 | Hepastab.......................... | ........................... | 2 cc. amp..................... | 6 | 1 |\n| | | ........................... | 10 cc. vial.................... | 1 | 1 |\n| 78 | Hepastab Forte...................... | ........................... | 1 cc. amp..................... | 6 | 1 |\n| | | ........................... | 2 cc. amp..................... | 3 | 1 |\n| | | ........................... | 10 cc. vial.................... | 1 | 1 |\n| 79 | Hepatex-T......................... | ........................... | 2 cc. amp..................... | 12 | 1 |\n| | | ........................... | 10 cc. vial.................... | 1 | 1 |\n| 80 | Hepolon.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |\n| | | ........................... | 10 cc. vial ................... | 1 | 1 |\n| 81 | Hyalase........................... | 1 mg........................ | amp........................ | 5 | 1 |\n| 82 | Hyoscine Hydrobromide............... | 1/150 gr...................... | amp........................ | 6 | .. |\n| | | 1/100 gr...................... | amp........................ | 6 | .. |\n| | | 1/75 gr...................... | amp........................ | 6 | .. |\n| | | 1/200 gr...................... | hypo. tab..................... | 100 | 1 |\n| | | 1/150 gr...................... | hypo. tab..................... | 100 | 1 |\n| | | 1/100 gr...................... | hypo. tab..................... | 100 | 1 |\n| | | 1/50 gr...................... | hypo. tab..................... | 100 | 1 |\n| | | 1/150 gr. per cc................. | 10 cc. vial.................... | 1 | |\n\n![](image.028.png)![](image.027.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantityor Number of Units. | Number of Repeats. |\n| ------------ | --------------------------------------------- | -------------------------------- | --------------------------------- | ----------------------------------- | ------------------ |\n| 83 | Insulin, Injection of................... | 20 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 20 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 60 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 80 U. per cc. .................. | 5 cc. vial..................... | 3 | 12 |\n| | | 80 U. per cc. .................. | 10 cc. vial.................... | 3 | 12 |\n| | | 100 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| 84 | Insulin (Crystalline), Injection of.......... | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| 85 | Insulin Globin Zinc, Injection of........... | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 80 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| 86 | Insulin, Isophane, Injection of............ | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 80 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| 87 | Insulin (Special P), Injection of........... | 20 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 60 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| 88 | Insulin Protamine Zinc, Injection of | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| | | 80 U. per cc................... | 5 cc. vial..................... | 3 | 12 |\n| | | 80 U. per cc................... | 10 cc. vial.................... | 3 | 12 |\n| 89 | Isoprenaline Hydrochloride.............. | 1 in 200 ..................... | ½ fl. oz. bottle................. | 1 | 1 |\n| | | 10 mg....................... | tablet....................... | 25 | 3 |\n| 90 | Isoprenaline Sulphate.................. | 20 mg....................... | tablet....................... | 25 | 3 |\n| | | 10 mg. per cc.................. | 7 cc. vial..................... | 1 | 1 |\n| | | ........................... | 10 cc. vial.................... | 1 | .. |\n\n![](image.030.png)![](image.029.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ----------------------------------------- | --------------------------------- | ------------------------------------------------------ | ------------------------------------ | ------------------ |\n| 91 | Kinaden.......................... | 10 U. per amp.................. | set containing 3 amps. and 3 amps of solvent | 1 | 1 |\n| 92 | Lanatoside C....................... | 0.2 mg. per cc.................. | 2 cc. amp..................... | 6 | 1 |\n| | | 0.25 mg...................... | tablet....................... | 40 | 1 |\n| 93 | Leptazol, Injection of................. | ........................... | 1 cc. amp..................... | 6 | .. |\n| | | ........................... | 1.1 cc. amp.................... | 6 | .. |\n| | | ........................... | 3 cc. amp..................... | 2 | .. |\n| | | ........................... | 5 cc. amp..................... | 1 | .. |\n| 94 | Livadex.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |\n| 95 | Liver Extract, Injection of.............. | 2 U.S.P. U. per cc............... | 1 cc. amp..................... | 6 | 1 |\n| | | 2 U.S.P. U. per cc............... | 10 cc. vial.................... | 6 | 1 |\n| | | 5 U.S.P. U. per cc............... | 2 cc. vial..................... | 6 | 1 |\n| | | 5 U.S.P. U. per cc............... | 10 cc. vial.................... | 1 | 1 |\n| | | 5 U.S.P. U. per cc............... | 20 cc. vial.................... | 1 | 1 |\n| | | 10 U.S.P. U. per cc.............. | 10 cc. vial.................... | 1 | 1 |\n| | | 15 U.S.P. U. per cc.............. | 5 cc. vial..................... | 1 | 1 |\n| 96 | Mepacrine Hydrochloride............... | 0.1 G........................ | tablet....................... | 100 | 1 |\n| 97 | Mepacrine Methanesulphonate, Injection of | 0.12 G....................... | amp........................ | 6 | 1 |\n| | | 0.36 G....................... | amp........................ | 6 | 1 |\n| 98 | Meprochol, Injection of................ | 3 mg. per cc................... | 1 cc. amp..................... | 6 | .. |\n| 99 | Mepyramine Maleate, Injection of......... | 2.5%....................... | 2 cc. amp..................... | 10 | .. |\n| 100 | Mercaptomerin Sodium................ | 1.4 G. per vial................. | set containing one vial and 10 cc. Water for Injection | 3 | .. |\n\n![](image.032.png)![](image.031.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

101

Mercuramide with Theophylline, Injection of

...........................

1 cc. amp.....................

10

..

...........................

2 cc. amp.....................

10

..

102

Mersalyl, Injection of..................

...........................

1 cc. amp.....................

12

..

...........................

2 cc. amp.....................

12

..

103

Methionine........................

50 G........................

bottle.......................

1

..

104

Methoin..........................

0.1 G........................

tablet.......................

100

1

105

Methyl Atropine Nitrate................

1/200 gr. per cc.................

1 cc. amp.....................

6

..

1/100 gr. per co.................

1 cc. amp.....................

6

..

0.

½ fl. oz. bottle.................

1

..

0.001 G......................

tablet.......................

20

1

106

Morphine Hydrochloride...............

¼ gr........................

hypo. tab.....................

20

..

107

Morphine Sulphate...................

⅙ gr........................

amp........................

6

..

¼ gr........................

amp........................

6

..

1/3 gr.......................

amp........................

6

..

½ gr........................

amp........................

6

..

1/12gr......................

hypo. tab.....................

20

..

1/3 gr.......................

hypo. tab.....................

20

..

⅙gr........................

hypo. tab.....................

20

..

¼ gr........................

hypo. tab.....................

20

..

1/3 gr.......................

hypo. tab.....................

20

..

½ gr........................

hypo. tab.....................

20

..

1 gr........................

hypo. tab.....................

12

..

¼ gr. per cc....................

10 cc. vial....................

1

..

½ gr. Per cc...................

10 cc. vial....................

1

..

\n```\n\n![](image.034.png)![](image.033.png) \nFirst Schedule—continued.\n\n```html\n

Item

Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

108

Morphine with Atropine ...............

\"\"Morphine Sulphate 1/12 gr.

1 hypo. tab....................

20

..

Atropine Sulphate 1/150 gr.

..

\"\"Morphine Sulphate ⅙ gr.

1 hypo. tab....................

20

..

Atropine Sulphate 1/150 gr.

..

\"\"Morphine Sulphate ⅙ gr

..

Atropine Sulphate 1/200 gr.

1 amp.......................

6

..

\"\"Morphine Sulphate ⅙ gr.

1 hypo. tab....................

20

..

Atropine Sulphate 1/180 gr.

..

\"\"Morphine Sulphate ⅙ gr.

1 hypo. tab....................

20

..

Atropine Sulphate 1/150 gr. per tab. or cc.

1 cc. amp.....................

6

..

10 cc. vial....................

1

..

\"\"Morphine Sulphate ⅙ gr.

..

Atropine Sulphate 1/120 gr.

1 amp.......................

6

..

\"\"Morphine Sulphate ¼ gr.

1 hypo. tab...................

20

..

Atropine Sulphate 1/160 gr. per tab. or cc.

1 cc. amp.....................

6

..

10 cc. vial....................

1

..

\"\"Morphine Sulphate ¼ gr.

1 hypo tab....................

..

Atropine Sulphate 1/120 gr.

I hypo. tab....................

20

..

\"\"Morphine Sulphate ¼ gr.

20

..

Atropine Sulphate 1/100 gr. per tab. or amp.

hypo. tab.....................

6

..

1 amp.......................

..

109

Morphine with Hyoscine ..............

\"\"Morphine Sulphate ¼ gr.

Hyoscine Hydrobromide 1/100 gr.

1 cc. amp.....................

6

..

110

Neoarsphenamine, Injection of...........

0.15 G......................

amp........................

2

1

0.3 G. ......................

amp........................

2

1

0.45 G......................

amp........................

2

1

0.6 G.......................

amp........................

2

1

0.75 G......................

amp........................

2

1

0.9 G.......................

amp........................

2

1

\n```\n\n![](image.045.png)![](image.044.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

111

Neo-Hepatex.......................

...........................

2 cc. amp.....................

12

1

...........................

10 cc. bottle..................

1

1

...........................

25 cc. bottle..................

1

1

112

Neostigmine Bromide.................

15 mg.......................

tablet.......................

100

1

113

Neostigmine Methylsulphate, Injection of

0.5 mg. per cc..................

1 cc. amp.....................

6

3

2.5 mg. per cc..................

5 cc. vial....................

1

1

114

Nikethamide, Injection of...............

...........................

1.7 cc. amp...................

5

..

...........................

2 cc. amp.....................

6

..

...........................

5 cc. amp.....................

3

..

...........................

5.5 cc. amp...................

3

..

115

Nucleotides, Injection of................

...........................

10 cc. amp....................

12

..

116

Ouabain, Injection of..................

0.25 mg......................

amp........................

3

..

0.5 mg.......................

amp........................

3

..

117

Oxophenarsine Hydrochloride, Injection of

0.04 G.......................

amp........................

2

1

0.06 G.......................

amp........................

2

1

118

Oxytocin, Injection of.................

...........................

0.5 co. amp...................

6

..

...........................

1 cc. amp.....................

6

..

119

Pamaquin.........................

0.01 G.......................

tablet.......................

45

..

0.018 G......................

tablet.......................

45

..

0.036 G......................

tablet.......................

45

..

\n```\n\n![](image.047.png)![](image.046.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

120

Papaveretum .......................

⅙ gr. per cc...................

1 cc. amp.....................

6

..

1/3 gr. per cc...................

1 cc. amp.....................

6

..

1/3 gr.......................

hypo. tab.....................

25

..

⅙gr........................

tablet.......................

20

..

121

Papaverine Hydrochloride ..............

1/3 gr. per cc...................

1 cc. amp.....................

6

..

1½ gr. per 5 cc.................

5 cc. amp.....................

6

..

2 gr. per 10 cc..................

10 cc. amp....................

6

..

1/3 gr.......................

tablet ......................

25

1

1½ gr.......................

tablet ......................

25

1

122

Paramethadione .....................

0.3 G........................

capsule.....................

100

2

123

Parenamine ........................

...........................

1,000 cc. bottle................

1

..

124

Penethamate Hydriodide ...............

100,000 U....................

vial........................

6

..

500,000 U....................

vial........................

3

..

125

Penicillin, Injection of .................

5,000 U......................

amp........................

6

..

15,000 U.....................

amp........................

6

..

100,000 U....................

amp........................

6

..

200,000 U....................

amp........................

6

..

500,000 U....................

amp........................

3

..

1,000,000 U...................

amp........................

1

..

1,500,000 U...................

amp........................

1

..

126

Penicillin, Procaine, Aqueous Suspension of

300,000 U....................

amp........................

3

..

400,000 U....................

vial ........................

3

..

600,000 U....................

vial ........................

2

..

900,000 U....................

vial ........................

2

..

1,000,000 U...................

vial ........................

1

..

1,500,000 U...................

vial ........................

1

..

\n```\n\n![](image.049.png)![](image.048.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ------------------------------------------------ | ---------------------------------- | -------------------------------- | ------------------------------------ | ------------------ |\n| 127 | Penicillin, Procaine (Crystalline), Injection of | 300,000 U.................... | amp........................ | 3 | .. |\n| | | 400,000 U.................... | amp........................ | 3 | .. |\n| | | 500,000 U.................... | amp........................ | 3 | .. |\n| | | 600,000 U.................... | amp........................ | 2 | .. |\n| | | 667,000 U.................... | amp........................ | 2 | .. |\n| | | 900,000 U.................... | amp........................ | 2 | .. |\n| | | 1,200,000 U................... | amp........................ | 1 | .. |\n| | | 1,500,000 U................... | amp........................ | 1 | .. |\n| 128 | Penicillin, Procaine, Oily Injection of | 300,000 U. per cc............... | 1 cc. amp..................... | 3 | .. |\n| | | 600,000 U.................... | amp........................ | 2 | .. |\n| | | 1,000,000 U................... | amp........................ | 1 | .. |\n| 129 | Pernaemon Crudum................... | ........................... | 2 cc amp..................... | 12 | 1 |\n| | | ........................... | 10 cc. vial.................... | 1 | 1 |\n| 130 | Pernaemon Fort...................... | ........................... | 1 cc. amp..................... | 12 | 1 |\n| | | ........................... | 5 cc. vial..................... | 1 | 1 |\n| 131 | Pernexin .......................... | ........................... | 2 cc. amp..................... | 6 | 1 |\n| 132 | Pertussis Vaccine (Phase 1) ............. | 1,000 M. per cc................. | 1 cc. amp..................... | 3 | 1 |\n| | | 5,000 M. per cc................. | 1 cc. amp..................... | 3 | 1 |\n| | | 5,000 M. per cc................. | 10 cc. vial.................... | 1 | .. |\n| | | 10,000 M. per cc................ | 1 cc. amp..................... | 3 | 1 |\n| | | 10,000 M. per cc................ | 10 cc. vial.................... | 1 | 1 |\n| | | 20,000 M. per cc................ | 1 cc. amp..................... | 3 | |\n| | | 20,000 M. per cc................ | 5 cc. vial..................... | 1 | .. |\n| | | 20,000 M. per cc................ | 10 cc. vial.................... | 1 | .. |\n| | | 60,000 M. per 1.5 cc.............. | 1.5 cc. vial................... | 1 | .. |\n| | | 50,000 M. per set ............... | set of 3 amps................... | 1 | .. |\n\n![](image.051.png)![](image.050.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | --------------------------------------- | --------------------------------------------------------------------- | ------------------------------- | ------------------------------------ | ------------------ |\n| 133 | Pethidine Hydrochloride ............... | 50 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |\n| | | 50 mg. per cc.................. | 2 cc. amp..................... | 6 | .. |\n| | | 50 mg. per cc.................. | 10 cc. vial................... | 1 | .. |\n| | | 50 mg. per cc.................. | 25 cc. bottle.................. | 1 | .. |\n| | | 50 mg. per cc.................. | 50 cc. bottle.................. | 1 | .. |\n| | | 25 mg....................... | tablet....................... | 25 | .. |\n| | | 50 mg....................... | tablet....................... | 25 | .. |\n| 134 | Pethidine Scopolamine | Pethidine Hydrochloride 100 mg. per amp. Scopolamine 0.43 mg. per amp | 2 cc. amp..................... | 6 | .. |\n| 135 | Phemitone ........................ | ½ gr....................... | tablet....................... | 100 | 1 |\n| | | 1 gr........................ | tablet....................... | 100 | 1 |\n| | | 3 gr........................ | tablet....................... | 100 | 1 |\n| 136 | Phenadoxone Hydrochloride............ | 10 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |\n| | | 10 mg....................... | tablet....................... | 25 | .. |\n| 137 | Phenobarbitone Sodium, Injection of | 1½ gr. per cc.................. | 1 cc. amp..................... | 6 | .. |\n| | | 3 gr. per cc................... | 1 cc. amp..................... | 6 | .. |\n| | | 3 gr. per 1.5 cc................. | 1.5 cc. amp................... | 6 | |\n| | | 3 gr. per 2 cc.................. | 2 cc. amp..................... | 6 | .. |\n| | | 3.1 gr. per 5 cc................. | 5 cc. amp..................... | 6 | .. |\n| 138 | Phenylindanedione................... | 50 mg....................... | tablet ...................... | 50 | .. |\n| 139 | Phenytoin Sodium................... | 0.03 G...................... | capsule..................... | 100 | 1 |\n| | | 0.1 G....................... | capsule...................... | 100 | 1 |\n| | | 0.1 G....................... | tablet....................... | 100 | 1 |\n| 140 | Phthalylsulphacetamide................ | 0.5 G....................... | tablet....................... | 100 | .. |\n\n![](image.054.png)![](image.053.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ----------------------------------------------------- | ------------------------------ | -------------------------------- | ------------------------------------ | ------------------ |\n| 141 | Phthalylsulphathiazole................. | 0.5 G........................ | tablet....................... | 100 | .. |\n| 142 | Physostigmine Sulphate................ | 1/100 gr...................... | hypo. tab..................... | 20 | .. |\n| 143 | Picrotoxin, Injection of................ | 3 mg........................ | amp........................ | 6 | .. |\n| | | 5 mg........................ | amp........................ | 6 | .. |\n| | | 0.3%....................... | 20 cc. bottle.................. | 1 | .. |\n| 144 | Pitressin Tannate in Oil, Injection of | ........................... | 1 cc. amp..................... | 12 | 1 |\n| 145 | Pituitary (Posterior Lobe), Injection of | ........................... | 0.5 cc. amp................... | 6 | .. |\n| | | ........................... | 1 cc. amp..................... | 6 | .. |\n| 146 | Primidone......................... | 0.25 G....................... | tablet....................... | 100 | 2 |\n| 147 | Procaine Hydrochloride in Normal Saline for Injection | 0.1% ....................... | 1 litre bottle.................. | 2 | 1 |\n| 148 | Procyclidine Hydrochloride............. | 5 mg........................ | tablet....................... | 100 | 1 |\n| 149 | Proguanil Hydrochloride............... | 0.1 G........................ | tablet....................... | 100 | 1 |\n| 150 | Promethazine Hydrochloride, Injection of | 2.5%....................... | 2 cc. amp..................... | 10 | .. |\n| 151 | Protamine Sulphate................... | 1%......................... | 5 mil. amp.................... | 6 | .. |\n| | | 1%......................... | 10 cc. amp.................... | 3 | .. |\n| 152 | Protolex.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |\n| | | ........................... | 10 cc. amp.................... | 1 | 1 |\n\n![](image.056.png)![](image.055.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

153

Pyridoxine Hydrochloride, Injection of

50 mg. per cc..................

1 cc. amp.....................

6

1

50 mg. per 2 cc.................

2 cc. amp.....................

6

1

50 mg. per cc..................

5 cc. vial.....................

1

1

50 mg. per cc..................

10 cc. vial....................

1

..

154

Quinidine Sulphate...................

3 gr........................

tablet.......................

100

1

155

Reticulogen........................

...........................

0.5 cc. amp....................

6

1

...........................

5 cc. amp.....................

1

1

156

Ringer’s Solution for Injection...........

...........................

1 litre bottle...................

4

1

157

Rondase..........................

3 mg........................

amp........................

6

1

158

Sodium Aurothiomalate, Aqueous Injection of

0.001 G......................

amp........................

1

3

0.002 G......................

amp........................

1

3

0.005 G......................

amp........................

1

3

0.01 G.......................

amp........................

1

3

0.02 G.......................

amp........................

1

3

0.05 G.......................

amp........................

6

1

0.1 G........................

amp........................

6

1

0.2G........................

amp........................

1

3

159

Sodium Aurothiomalate, Oily Injection of

0.01 G.......................

amp........................

1

3

0.02 G.......................

amp........................

1

3

0.05 G.......................

amp........................

6

1

160

Sodium Chloride Hypertonic Solution for Injection

3%.........................

1 litre bottle...................

2

1

5%.........................

1 litre bottle...................

2

1

\n```\n\n![](image.058.png)![](image.057.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | -------------------------------------------------------------------- | ------------------------------ | --------------------------------- | ------------------------------------ | ------------------ |\n| 161 | Sodium Chloride Physiological Solution for Injection | ........................... | 2 cc. amp..................... | 6 | 1 |\n| | | ........................... | 5 cc. amp..................... | 6 | 1 |\n| | | ........................... | 10 cc. amp.................... | 6 | 1 |\n| | | ........................... | 20 cc. amp.................... | 6 | 1 |\n| | | ........................... | 50 cc. amp.................... | 3 | 1 |\n| | | ........................... | 1 litre bottle .................. | 2 | 1 |\n| 162 | Sodium Chloride Physiological Solution (with Dextrose) for Injection | 5% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |\n| | | 10% Dextrose.................. | 1 litre bottle................... | 2 | 1 |\n| | | 20% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |\n| | | 25% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |\n| 163 | Sodium Sulphate Solution for Injection | 4.28%....................... | 1 litre bottle .................. | 2 | 1 |\n| 164 | Solapsone......................... | 7 gr....................... | tablet ....................... | 200 | .. |\n| 165 | Succinylsulphathiazole................. | 0.5 G........................ | tablet ....................... | 100 | .. |\n| 166 | Sulphacetamide...................... | 0.5 G........................ | tablet ....................... | 50 | .. |\n| 167 | Sulphadiazine....................... | 0.3 G ....................... | tablet ....................... | 50 | .. |\n| | | 0.5 G........................ | tablet ....................... | 50 | .. |\n| 168 | Sulphadimidine...................... | 0.25 G....................... | tablet ....................... | 50 | .. |\n| | | 0.5 G........................ | tablet ....................... | 50 | .. |\n\n![](image.060.png)![](image.059.png) \nFirst Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

169

Sulphafurazole......................

0.5 G.......................

tablet.......................

50

..

170

Sulphaguanidine....................

0.5 G.......................

tablet.......................

100

..

171

Sulphamerazine.....................

0.5 G.......................

tablet.......................

50

..

172

Sulphamethizole....................

0.1 G.......................

tablet.......................

30

..

173

Sulphamethizole....................

0.5G........................

tablet.......................

50

..

174

Sulpharsphenamine, Injection of..........

0.16........................

amp........................

2

1

0.15 G......................

amp........................

2

1

0.3 G.......................

amp........................

2

1

0.45 G......................

amp........................

2

1

0.6 G.......................

amp........................

2

1

0.75 G......................

amp........................

2

1

0.9 G.......................

amp........................

2

1

175

Sulphathiazole......................

0.3 G.......................

capsule......................

50

..

0.5 G.......................

tablet.......................

50

..

176

Sulphonamides, Mixed, (A)—Two Sulphonamides

0.25 G......................

tablet.......................

50

..

0.3 G.......................

tablet.......................

50

..

0.5 G.......................

tablet.......................

50

..

\n```\n\n![](image.062.png)![](image.061.png) \nFirst Schedule—continued.\n\n```html\n

Item

Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

177

Sulphonamides, Mixed, (B)—Three Sulphonamides

0.25 G......................

tablet.......................

50

..

0.3 G.......................

tablet.......................

50

..

0.33 G......................

tablet.......................

50

..

0.5 G.......................

tablet.......................

50

..

178

Sulphonamides, Mixed, (C)—Four Sulphonamides

0.3 G.......................

tablet.......................

50

..

0.5 G.......................

tablet.......................

50

..

179

Suprarenal Cortex Extract, Injection of

200γ per cc...................

10 cc. bottle..................

3

1

..........................

10 cc. vial....................

3

1

180

T.A.B. Vaccine (Antityphoid-paratyphoid)

1 cc. containing—

1 cc. amp.....................

3

..

1,000 M. Typhosus

10 cc. vial....................

1

..

500 M. Para-typhosus A

500 M. Para-typhosus B

181

Tetanus Antitoxin....................

500 I.U......................

amp........................

6

1

1,000 I.U.....................

amp........................

6

1

1,500 I.U.....................

amp........................

6

1

5,000 I.U.....................

amp........................

6

1

10,000 I.U....................

amp........................

6

1

182

Tetanus Toxoid (Formalinized)...........

..........................

1 cc. amp.....................

3

..

183

Theophylline with Ethylenediamine

0.366 G. per 10 mil..............

10 mil. amp...................

6

..

0.732 G. per 2 mil...............

2 mil. amp....................

6

..

0.48 G. per 2 mil................

2 mil. I.M. amp.................

6

..

0.5 G. per 2 mil................

2 mil. I.M. amp.................

6

..

0.24 G. per 10 mil...............

10 mil. I.V. amp................

6

..

0.25 G. per 10 mil...............

10 mil. I.V. amp................

6

..

1½ gr.......................

tablet.......................

100

1

2.34 gr......................

tablet ......................

100

1

\n```\n\n![](image.064.png)![](image.063.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ---------------------------------------- | ------------------------------ | ----------------------------- | ------------------------------------ | ------------------ |\n| 184 | Thiacetazone....................... | 25 mg....................... | tablet....................... | 100 | .. |\n| | | 50 mg....................... | tablet....................... | 50 | .. |\n| 185 | Thiouracil, Methyl................... | 0.05 G....................... | tablet....................... | 100 | 1 |\n| | | 0.1 G........................ | tablet....................... | 100 | 1 |\n| | | 0.2 G........................ | tablet....................... | 100 | 1 |\n| 186 | Thiouracil, Propyl.................... | 25 mg....................... | tablet....................... | 100 | 1 |\n| | | 50 mg....................... | tablet....................... | 100 | 1 |\n| 187 | Thyroid B.P........................ | 1/32 gr....................... | tablet....................... | 100 | 3 |\n| | | 1/16 gr...................... | tablet....................... | 100 | 3 |\n| | | 1/10 gr...................... | tablet....................... | 100 | 3 |\n| | | ⅛ gr......................... | tablet....................... | 100 | 3 |\n| | | ¼ gr........................ | tablet....................... | 100 | 3 |\n| | | ½ gr........................ | tablet....................... | 100 | 3 |\n| | | 1 gr........................ | tablet....................... | 100 | 3 |\n| | | 1½ gr........................ | tablet....................... | 100 | 3 |\n| | | 2 gr........................ | tablet....................... | 100 | 3 |\n| | | 2½ gr........................ | tablet....................... | 100 | 3 |\n| | | 5 gr........................ | tablet....................... | 100 | 3 |\n| 188 | Tiger Snake Anti-venene............... | 1,500 U...................... | amp........................ | 4 | 1 |\n| 189 | Triethanolamine Trinitrate.............. | 1 mg........................ | tablet....................... | 50 | 1 |\n| 190 | Troxidone......................... | 0.3 G........................ | capsule..................... | 100 | 1 |\n| | | 0.15 G....................... | tablet....................... | 100 | 1 |\n\n![](image.066.png)![](image.065.png) \nFirst Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |\n| ------------ | ------------------------------------ | ------------------------------- | ---------------------------- | ------------------------------------ | ------------------ |\n| 191 | Vasopressin, Injection of .......... | ........................ | 0.5 cc. amp................. | 6 | .. |\n| | | ........................ | 1 cc. amp.................. | 6 | .. |\n| 192 | Vitamin K, Aqueous Injection of .... | 2.5 mg. per 0.5 cc............. | 0.5 cc, amp................. | 6 | 1 |\n| | | 5 mg. per cc. ............... | 1 cc. amp.................. | 6 | 1 |\n| | | 10 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |\n| | | 75 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |\n| 193 | Vitamin K, Oily Injection of ....... | 5 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |\n| | | 10 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |\n| 194 | Vitamin K (Oral) ............... | 1 mg..................... | capsule ................... | 100 | 1 |\n| | | 1 mg..................... | tablet .................... | 100 | 1 |\n| | | 4 mg..................... | capsule ................... | 100 | 1 |\n| | | 4.8 mg. ................... | tablet .................... | 100 | 1 |\n| | | 5 mg..................... | tablet.................... | 100 | 1 |\n| | | 10 mg.................... | tablet .................... | 100 | 1 |\n| 195 | Water for Injection .............. | ......................... | 2 cc. amp.................. | 6 | 1 |\n| | | ........................ | 5 cc. amp. ................. | 12 | 1 |\n| | | ........................ | 10 cc. amp. ................ | 12 | 1 |\n| 196 | Wydase ..................... | 150 U..................... | amp. .................... | 5 | 1 |\n\n![](image.067.png) \nSECOND SCHEDULE.\n\nReg. 8.\n\n![](image.068.png)Drugs and Medicinal Preparations that may be Prescribed for Supply, Supplied and Received as General Pharmaceutical Benefits Only for the Treatment of a Disease or Purpose.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

Disease or Purpose.

1

Aureomycin ..............

50 mg. ..........

capsule ..........

25

..

Acute amoebic dysentery

100 mg. .........

capsule ..........

25

..

Acute and sub-acute bacterial endocarditis-streptococcus faecalis

250 mg. ..........

capsule ..........

16

..

100 mg. .........

vial ............

6

..

Staphylococcal infections that do not respond to penicillin

Pneumonia that has not responded to penicillin or to sulphonamides

Psittacosis

Urinary tract infections due to streptococcus faecalis

2

Calcium Para-aminosalicylate

1.5G. ...........

cachet ..........

200

1

Tuberculosis

2.0 G. ...........

cachet ..........

200

1

5 gr. ............

tablet ...........

200

1

7½ gr. ..........

tablet ...........

200

1

...............

100 G. tin ........

1

1

................

400 G. tin ........

1

1

3

Caramiphen Hydrochloride

0.05 G...........

tablet ...........

100

1

Parkinsonism

4

Chloramphenicol ...........

0.125 G. .........

capsule ..........

16

..

Typhoid fever

0.25 G. ..........

capsule ..........

16

..

Brucellosis

Typhus and other rickettsial diseases

Influenzal meningitis

Granuloma inguinale

Lymphogranuloma venereum

Whooping cough (haemophilus pertussis) Infections due to haemophilus influenza Acute laryngo-tracheo-bronchitis

\n```\n\n![](image.070.png)![](image.069.png) \nSecond Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number
of Repeats.

Disease or Purpose.

4—

Chloramphenicol—continued.

Salmonella infections

contd.

Severe gastro-enteritis in children

Staphylococcal infections that do not respond to either penicillin or aureomycin

Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides

Meningitis due to bacterium coli if other forms of treatment are unsuccessful

5

Chloramphenicol Palmitate

0.125 G. per 4 cc.

60 cc. bottle ......

1

..

Any disease or purpose specified in this column in relation to chloramphenicol

6

Cortisone Acetate ...........

25 mg. .........

tablet ..........

40

1

Acute rheumatic carditis

25 mg. per cc. ....

20 cc. vial .......

1

..

Addison’s disease

50 mg. per cc. ....

10 cc. vial .......

1

..

Total adrenalectomy

Status asthmaticus

7

Deoxycortone Acetate, Aqueous Injection of

5 mg. ..........

amp. ...........

4

..

Addison’s disease

50 mg. .........

amp. ...........

1

..

8

Deoxycortone Acetate, Aqueous Suspension of

25 mg. ..........

amp. ...........

1

..

Addison’s disease

50 mg. .........

amp. ...........

1

..

9

Deoxycortone Acetate, Oily Injection of

2 mg. ..........

amp. ...........

4

..

Addison’s disease

5 mg. ..........

amp. ...........

4

..

10 mg. ..........

amp. ...........

4

..

50 mg. ..........

implant .........

1

..

100 mg. ........

implant .........

1

..

5 mg. per cc. .....

5 cc. vial ........

1

..

10 mg. per cc......

10 cc. vial .......

1

..

\n```\n\n![](image.072.png)![](image.071.png) \nSecond Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |\n| ------------ | -------------------------------- | -------------------- | ------------------- | ------------------------------------ | ------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| 10 | Dienoestrol ............... | 5 mg............ | tablet ........... | 100 | 1 | Carcinoma of the prostate |\n| | | 10 mg........... | tablet ........... | 100 | 1 | Mammary carcinoma |\n| 11 | Dihydrostreptomycin ......... | 1 G............. | vial ............ | 5 | 3 | Any disease or purpose specified in this column in relation to streptomycin, but only if the person being treated for that disease or purpose is allergic to streptomycin |\n| 12 | Folic Acid ................ | 15 mg. per cc....... | 1 cc. amp ........ | 12 | .. | Sprue or the sprue-like syndrome |\n| | | 5 mg............ | tablet ........... | 100 | 1 | |\n| 13 | Isoniazid ................. | 50 mg. ........... | tablet ............ | 100 | 1 | Tuberculosis |\n| | | 100 mg. ......... | tablet ........... | 100 | 1 | |\n| 14 | Pancreatin ................ | 5 gr. ............ | tablet ........... | 100 | .. | Fibrocystic disease of the pancreas |\n| 15 | Para-Aminosalicylic Acid ..... | 0.3 G. ........... | tablet ........... | 200 | 1 | Tuberculosis |\n| | | 0.5 G. ........... | tablet ........... | 200 | 1 | |\n| 16 | Phenindamine Tartrate ........ | 25 mg. .......... | tablet ........... | 100 | 1 | Parkinsonism |\n| 17 | Progesterone, Injection of...... | 5 mg. ........... | amp............. | 6 | .. | Threatened abortion |\n| | | 10 mg. .......... | amp. ............ | 6 | .. | |\n| | | 20 mg. .......... | I.V. amp.......... | 3 | .. | |\n| 18 | Quinine Bisulphate .......... | 5 gr.............. | tablet ............ | 100 | 1 | Malaria |\n\n![](image.074.png)![](image.073.png) \nSecond Schedule—continued.\n\n| Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |\n| ------------ | ------------------------------ | --------------------- | ------------------- | ------------------------------------ | ------------------ | ----------------------------------------------------------------- |\n| 19 | Quinine Dihydrochloride ...... | 3 gr. per cc......... | 1 cc. amp......... | 6 | 1 | Malaria |\n| | | 6¼ gr. per cc....... | 1 cc. amp......... | 6 | 1 | |\n| | | 9¼ gr. per 2 cc...... | 2 cc. amp......... | 6 | 1 | |\n| | | 15½ gr. per 2 cc..... | 2 cc. amp......... | 6 | 1 | |\n| | | 5 gr............. | capsule ......... | 100 | 1 | |\n| | | 5 gr............. | tablet ........... | 100 | 1 | |\n| 20 | Quinine Hydrochloride ....... | 5 gr............. | tablet ........... | 100 | 1 | Malaria |\n| 21 | Quinine Sulphate ........... | 5 gr............. | tablet ........... | 100 | 1 | Malaria |\n| 22 | Sodium Para-Aminosalicylate | 1.5G............. | cachet .......... | 200 | 1 | Tuberculosis |\n| | | 2.0.G............ | cachet .......... | 200 | 1 | |\n| | | 0.5 G ........... | capsule ......... | 200 | 1 | |\n| | | 5 gr............. | tablet ........... | 200 | 1 | |\n| | | 7½ gr............ | tablet ........... | 200 | 1 | |\n| | | 20% ............ | 10 cc. vial ....... | 6 | .. | |\n| 23 | Stilboestrol ............... | 1 mg............. | amp............ | 6 | .. | Carcinoma of the prostate |\n| | | 5 mg............. | amp............ | 6 | .. | Mammary carcinoma |\n| | | 1 mg. ........... | tablet ........... | 100 | 1 | |\n| | | 5 mg............. | tablet ........... | 100 | 1 | |\n| | | 10 mg............ | tablet ........... | 100 | 1 | |\n| 24 | Streptomycin .............. | 1 G.............. | vial ............ | 5 | 3 | Infections due to haemophilus influenza Chancroid |\n| | | | | | | Pneumonia due to bacillus Friedlander |\n| | | | | | | Acute tuberculosis |\n| | | | | | | Acute exacerbations in chronic tuberculosis Salmonella infections |\n\n![](image.076.png)![](image.075.png) \nSecond Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

Disease or Purpose.

24— contd.

Streptomycin—continued.

Bacillary dysentery not responding to sulphonamides

Surgical conditions of the bowel and of the thoracic organs

Tularaemia

Infections due to pseudomonas pyocyaneus

25

Streptomycin Sulphate Solution for Injection

250,000 U. per mil.

4 mil. vial ........

5

3

Any disease or purpose specified in this column in relation to streptomycin

26

Terramycin ...............

50 mg..........

capsule ..........

25

..

Acute amoebic dysentery

100 mg.........

capsule ..........

25

..

Acute and sub-acute bacterial endocarditis-streptococcus faecalis

250 mg.........

capsule ..........

16

..

50 mg..........

tablet ...........

25

..

Staphylococcal infections that do not respond to penicillin

100 mg. ........

tablet ...........

25

..

250 mg.........

tablet ...........

16

..

Pneumonia that has not responded to penicillin or to sulphonamides

100 mg.........

vial ............

6

..

250 mg. per 10 cc..

10 cc. vial ........

6

..

Psittacosis

Urinary tract infections due to streptococcus faecalis

27

Terramycin Oral Suspension

0.25 G. per 5 cc....

1 fl. oz. bottle .....

1

..

Any disease or purpose specified in this column in relation to terramycin

28

Testosterone ..............

100 mg.........

implant ..........

1

..

Mammary carcinoma

150 mg.........

implant ..........

1

..

Castration

200 mg.........

implant ..........

1

..

29

Testosterone, Methyl .........

25 mg..........

tablet ...........

25

1

Mammary carcinoma

50 mg..........

tablet ...........

25

1

Castration

\n```\n\n![](image.078.png)![](image.077.png) \nSecond Schedule—continued.\n\n```html\n

Item Number.

Name or Formula.

Strength.

Form of Unit.

Maximum Quantity or Number of Units.

Number of Repeats.

Disease or Purpose.

30

Testosterone Oenanthate, Injection of

250 mg. per cc.....

1 cc. amp.........

1

..

Mammary carcinoma Castration

31

Testosterone Phenyl Propionate, Injection of

50 mg. per cc......

1 cc. amp.........

3

..

Mammary carcinoma Castration

50 mg. per cc......

5 cc. vial .........

1

..

32

Testosterone Propionate, Injection of

25 mg. per cc......

1 cc. amp.........

12

..

Mammary carcinoma Castration

50 mg. per cc......

1 cc. amp.........

12

..

50 mg. per cc......

10 cc. vial........

1

..

100 mg. per 2 mil...

2 mil. amp........

1

..

100 mg.........

implant .........

1

..

33

Tetracycline ..............

50 mg. .........

capsule ..........

25

..

Any disease or purpose specified in this column in relation to aureomycin

100 mg..........

capsule ..........

25

..

250 mg. ........

capsule ..........

16

..

50 mg. .........

tablet ...........

25

..

100 mg..........

tablet ...........

25

..

250 mg..........

tablet ...........

16

..

100 mg. ........

vial .............

6

..

34

Vitamin B12, Injection of ......

10γ per cc.......

1 cc. amp.........

12

1

Established megalocytic anaemias

15γ per cc........

1 cc. amp.........

12

1

20γ per cc........

1 cc. amp.........

12

1

50γ per cc........

1 cc. amp.........

6

1

100γ per cc.......

1 cc. amp.........

1

1

100γ per cc.......

10 cc. vial ........

1

..

200γ per cc.......

1 cc. amp.........

1

..

l,000γ per cc......

1 cc. amp.........

1

..

l,000γ per cc......

10 cc. vial ........

1

..

\n```\n\nTHIRD SCHEDULE.\n\nReg. 10.\n\nPensioner Benefits Additional to those Covered by Monograph in the British Pharmacopoeia.\n\n| Item No. | Name or Formula of Drug or Medicinal Preparation. |\n| -------- | ------------------------------------------------- |\n| 1 | Acetonum B.P.C. |\n| 2 | Acetum Scillae |\n| 3 | Acidum Hydrocyanicum Dilution B.P.C. |\n| 4 | Acidum Sulphuricum Dilutum B.P.C. |\n| 5 | Acidum Hypophosphorosum Dilutum |\n| 6 | Acriflavina |\n| 7 | Adeps |\n| 8 | Adeps Benzoinatus |\n| 9 | Aethylenum |\n| 10 | Agar |\n| 11 | Amidopyrina |\n| 12 | Ammonii Bromidum B.P.C. |\n| 13 | Aqua (Potable Water) |\n| 14 | Aqua Anisi B.P.C. |\n| 15 | Aqua Chlorbutolis A.P.E. |\n| 16 | Argentoproteinum Mite B.P.C. |\n| 17 | Balsamum Peruvianum |\n| 18 | Betanaphthol |\n| 19 | Caffeina Citrata B.P.C. |\n| 20 | Caffeina et Sodii Benzoas |\n| 21 | Calcii Mandelas |\n| 22 | Capsulae Sodii Pentobarbitoni |\n| 23 | Cera Flava |\n| 24 | Chiniofonum |\n| 25 | Chromii Trioxidum |\n| 26 | Codeina |\n| 27 | Cremor Penicillini Sterilisatus |\n| 28 | Ephedrinae Sulphas B.P.C. |\n| 29 | Extractum Colchici Siccum |\n| 30 | Extractum Colocynthidis Compositum |\n| 31 | Extractum Ergotae Liquidum |\n| 32 | Extractum Fellis Bovini |\n| 33 | Extractum Glycyrrhizae |\n| 34 | Extractum Hepatis Liquidum |\n| 35 | Extractum Krameriae Siccum |\n| 36 | Extractum Senegae Liquidum |\n| 37 | Ferri Carbonas Saccharatus |\n| 38 | Glycerinum Acidi Borici |\n| 39 | Glycerinum Boracis |\n| 40 | Hexoestrol |\n| 41 | Hydrargyrum cum Creta |\n| 42 | Infusum Aurantii |\n| 43 | Infusum Aurantii Concentratum |\n| 44 | Infusum Buchu B.P.C. |\n| 45 | Infusum Calumbae |\n| 46 | Infusum Calumbae Concentratum |\n| 47 | Infusum Calumbae Recens |\n| 48 | Infusum Caryophylli |\n| 49 | Infusum Caryophylli Concentratum |\n| 50 | Infusum Senegae |\n| 51 | Infusum Senegae Concentratum |\n| 52 | Infusum Sennae |\n| 53 | Infusum Sennae Concentratum |\n| 54 | Injectio Caffeinae et Sodii Benzoatis |\n| 55 | Injectio Oestradiolis Dipropionatis |\n| 56 | Injectio Penicillini Oleosa |\n| 57 | Injectio Physostigminae Salicylatis |\n| 58 | Injectio Pituitarii Posterioris |\n\n \nThird Schedule—continued.\n\n| Item No. | Name or Formula of Drug or Medicinal Preparation. |\n| -------- | ------------------------------------------------- |\n| 59 | Injectio Procainae et Adrenalinae Mitis |\n| 60 | Injectio Sodii Citratis Anticoagulans |\n| 61 | Injectio Sodii Citratis cum Dextroso |\n| 62 | Injectio Strychninae Hydrochloridi |\n| 63 | Injectio Sulphadiazinae Sodii |\n| 64 | Iodoformum |\n| 65 | Ipomoeae Resina |\n| 66 | Laevulosum |\n| 67 | Linimentum Aconiti |\n| 68 | Linimentum Belladonnae |\n| 69 | Liquor Ammoniae Aromaticus B.P.C. |\n| 70 | Liquor Glycerylis Trinitratis B.P.C. |\n| 71 | Liquor Magnesii Bicarbonatis |\n| 72 | Magenta B.P.C. |\n| 73 | Magnesii Phosphas B.P.C. |\n| 74 | Mel Depuratum |\n| 75 | Mistura Aluminii Hydroxidi A.P.F. |\n| 76 | Mistura Sennae Composita |\n| 77 | Oestradiolis Dipropionas |\n| 78 | Oestronum |\n| 79 | Oculentum Cocainae |\n| 80 | Oculentum Physostigminae |\n| 81 | Oleum Cajuputi |\n| 82 | Oleum Cari |\n| 83 | Oleum Citronellae B.P.C. |\n| 84 | Oleum Cocois B.P.C. |\n| 85 | Oleum Pini B.P.C. |\n| 86 | Oxymel Scillae |\n| 87 | Pelletierinae Tannas |\n| 88 | Phenazonum |\n| 89 | Pilula Aloes |\n| 90 | Pilula Aloes et Nux Vomica B.P.C. |\n| 91 | Pilula Colocynthidis et Hyoscyami |\n| 92 | Pilula Digitalis Composita B.P.C. |\n| 93 | Pilula Ferri Carbonatis |\n| 94 | Pilula Hydrargyri |\n| 95 | Pilula Phenolphthalein Composita B.P.C. |\n| 96 | Pilula Rhei Composita |\n| 97 | Pilula Sodii Oleatis Composita A.P.F. |\n| 98 | Pix Carbonis B.P.C. |\n| 99 | Potassii Acetas |\n| 100 | Potassii Chloras |\n| 101 | Quininae et Aethylis Carbonas |\n| 102 | Sapo Animalis |\n| 103 | Sapo Durus |\n| 104 | Sodii Carbonas Exsiccatus |\n| 105 | Sodii Nitris |\n| 106 | Sodii Phosphas Exsiccatus |\n| 107 | Sodii Sulphas Exsiccatus |\n| 108 | Spiritus Aetheris Nitrosi |\n| 109 | Spiritus Cajuputi |\n| 110 | Spiritus Camphorae |\n| 111 | Strychnina B.P.C. |\n| 112 | Sulphacetamidum |\n| 113 | Sulphadiazina Sodium |\n| 114 | Sulphonal |\n| 115 | Suppositoria Acidi Tannici |\n| 116 | Suppositoria Belladonnae |\n| 117 | Suppositoria Bismuthi Subgallatis |\n| 118 | Suppositoria Cocainae |\n| 119 | Suppositoria Hamamelidis et Zinci Oxidi |\n| 120 | Suppositoria Iodoformi |\n\nThird Schedule—continued.\n\n| Item No. | Name or Formula of Drug or Medicinal Preparation. |\n| -------- | ------------------------------------------------------- |\n| 121 | Suppositoria Morphinae |\n| 122 | Suppositoria Phenolis |\n| 123 | Syrupus Ferri Phosphatis Compositus |\n| 124 | Syrupus Glucosi Liquidi |\n| 125 | Syrupus Glycerophosphatum Compositus A.P.F. |\n| 126 | Syrupus Limonis Neutralis A.P.F. |\n| 127 | Syrupus Pruni Serotinae |\n| 128 | Syrupus Ruber A.P.F. |\n| 129 | Syrupus Scillae |\n| 130 | Syrupus Theriacae Aureae A.P.F. |\n| 131 | Tabellae Acidi Acetylsalicylic Co. B.P.C. |\n| 132 | Tabellae Aminophyllinae et Phenobarbitonum B.P.C. |\n| 133 | Tabellae Aminophyllinae gr. 1½ cum Phenobarbitoni gr. ½ |\n| 134 | Tabellae Ammonii Chloridi B.P.C. |\n| 135 | Tabellae Calcii Gluconatis B.P.C. |\n| 136 | Tabellae Ephedrinae gr. ½ cum Phenobarbitoni gr. ½ |\n| 137 | Tabellae Hexoestrolis |\n| 138 | Tabellae Hydrargyri cum Creta |\n| 139 | Tabellae Oestroni |\n| 140 | Tabellae Phenazoni |\n| 141 | Tabellae Potassii Chloratis |\n| 142 | Tabellae Sodii Pentobarbitoni |\n| 143 | Tabellae Sodii Salicylatis |\n| 144 | Tabellae Theobrominae et Phenobarbitoni B.P.C. |\n| 145 | Tabellae Theobrominae et Sodii Salicylatis B.P.C. |\n| 146 | Tabellae Thiouracili |\n| 147 | Talcum Purificatum B.P.C. |\n| 148 | Theophyllina et Sodii Acetas |\n| 149 | Thiouracilum |\n| 150 | Tinctura Calumbae |\n| 151 | Tinctura Capsici |\n| 152 | Tinctura Catechu |\n| 153 | Tinctura Cocci |\n| 154 | Tinctura Gelsemii B.P.C. |\n| 155 | Tinctura Lobeliae Aetherae B.P.C. |\n| 156 | Tinctura Myrrhae |\n| 157 | Tinctura Persionis A.P.F. |\n| 158 | Tinctura Quassiae |\n| 159 | Tinctura Scillae |\n| 160 | Tinctura Senegae |\n| 161 | Tinctura Strophanthi |\n| 162 | Tinctura Tolutana |\n| 163 | Tinctura Valerianae ammoniata |\n| 164 | Triethanolamina B.P.C. |\n| 165 | Unguentum Capsici |\n| 166 | Unguentum Gallae cum Opio B.P.C. |\n| 167 | Unguentum Hydrargyri Compositum |\n| 168 | Unguentum Hydrargyri Subchloridi |\n| 169 | Unguentum Phenolis |\n| 170 | Unguentum Zinci Oleatis |\n| 171 | Unguentum Zinci Oxidi Aquosum |\n| 172 | Xylenum B.P.C. |\n\n \nFourth Schedule.\n\n6. The Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words and figures—\n\n| “Tablets— | |\n| ------------------------------------------------------------------------ | --- |\n| Tablets of phenobarbitone ........................................ | 100 |\n| Tablets of phenobarbitone sodium ................................... | 100 |\n| Other tablets ................................................. | 25” |\n| and inserting in their stead the words and figures— | |\n| “Tablets— | |\n| Tablets of aminophylline with phenobarbitone ........................... | 100 |\n| Tablets of calcium gluconate ....................................... | 100 |\n| Tablets of phenobarbitone ........................................ | 100 |\n| Tablets of phenobarbitone sodium ................................... | 100 |\n| Tablets of theobromine with phenobarbitone ............................ | 100 |\n| Other tablets ................................................. | 25” |\n\nFifth Schedule.\n\n7. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the figures and words—\n\n| “126 | Penicillin, Procaine, Aqueous Suspension of | Vial .. | 12” |\n| ---- | ------------------------------------------- | ------- | --- |\n\nand inserting in their stead the figures and words—\n\n| “126 | Penicillin, Procaine, Aqueous Suspension of | Ampoule or Vial | 12”. |\n| ---- | ------------------------------------------- | --------------- | ---- |\n\n![](image.079.png)By Authority: L. F. Johnston, Commonwealth Government Printer, Canberra.","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":1920},"content_quality":"ok","complexity_score":7,"scope_assessment":{"changed":false,"description":"This amendment remains within the original scope of the Pharmaceutical Benefits Regulations. It performs administrative updates to drug listings, clarifies definitions for payment purposes, and tightens restrictions on specific items (Water for Injection). It does not expand the scheme into new areas or fundamentally alter the subsidy mechanism."},"complexity_factors":["Extensive tabular First Schedule with 150+ specific drug items, each with multiple variations of strength and form","Detailed quantity restrictions and repeat prescription limits for each drug variant","Cross-references to existing regulation numbers (Reg 2, Reg 8, Reg 9, Reg 19)","Conditional logic for Water for Injection (restricted to specific co-prescribed drugs)","Multiple schedule amendments (First, Second, and Third Schedules repealed and replaced)","Technical pharmaceutical terminology (hypodermic tablets, ampoules, specific chemical compounds)"],"plain_english_summary":"This amendment tightens how Australia’s Pharmaceutical Benefits Scheme operates: it defines \"brand\" for pricing, limits prescriptions of Water for Injection to specific clinical uses, lets doctors prescribe by \"a brand of that benefit,\" and replaces the old drugs list with a detailed new schedule of medicines, strengths, forms and repeat limits. \n\nIt affects prescribers, pharmacists, patients and manufacturers by clarifying subsidy coverage and conditions, shaping access and government expenditure on medicines."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment","history":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment/history","analysis":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment/analysis","conflicts":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment/conflicts","importantCases":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment/important-cases","documents":"/api/acts/national-health-pharmaceutical-benefits-regulations-amendment/documents"}}